Home » PFIZER ACQUIRES GLOBAL RIGHTS OF SCHWARZ PHARMA'S NEW DRUG
PFIZER ACQUIRES GLOBAL RIGHTS OF SCHWARZ PHARMA'S NEW DRUG
June 13, 2006
Pharmaceutical giant Pfizer Inc (PFE.NYS) Tuesday announced that it had completed
the acquisition of the worldwide rights of Schwarz Pharma AG's (SRZ) new drug
candidate, fesoterodine, for the treatment of an overactive bladder.